Clonal dissemination of mupirocin-resistant staphylococci in Greek hospitals

J Antimicrob Chemother. 2004 Jan;53(1):105-8. doi: 10.1093/jac/dkh028. Epub 2003 Dec 4.

Abstract

Objectives: To determine the rates of mupirocin resistance in staphylococci during a 4 year period (1999-2002) in Greece.

Materials: A total of 1200 Staphylococcus aureus and 2760 coagulase-negative staphylococci (CoNS), consecutively collected from four Greek hospitals located in different geographical areas, were tested for susceptibility to mupirocin using the Etest and a reference agar dilution method.

Results: Twenty-four S. aureus (2%) and 532 CoNS (19.2%) were found to be mupirocin-resistant during the study period. High-level mupirocin resistance was detected in 20 S. aureus (1.6%) and in 440 CoNS (15.9%), respectively. No variations in the rates of mupirocin-resistant S. aureus in relation to the year of collection were observed. In contrast, the rate of mupirocin-resistant CoNS increased dramatically from 9% in 1999, to 14% in 2000, 20% in 2001 and reached 33% in 2002. PFGE analysis revealed the presence of one main clone (A) among mupirocin-resistant S. aureus and two main clones (i and a) among Staphylococcus epidermidis isolates.

Conclusions: In Greece, the rate of mupirocin-resistant S. aureus has remained low and steady since 1999. The high rate of mupirocin-resistant CoNS (33%) in 2002 was due mainly to clonal dissemination of epidemic hospital clones.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Coagulase / metabolism
  • Cross Infection / microbiology*
  • Drug Resistance, Bacterial*
  • Genotype
  • Greece
  • Humans
  • Microbial Sensitivity Tests
  • Mupirocin / pharmacology*
  • Staphylococcal Infections / microbiology*
  • Staphylococcus / drug effects*
  • Staphylococcus / genetics
  • Staphylococcus / isolation & purification
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / genetics
  • Staphylococcus aureus / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Coagulase
  • Mupirocin